This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Patterson Companies Reports Fiscal 2014 First Quarter Operating Results

Patterson Companies, Inc. (Nasdaq: PDCO) today reported that consolidated sales totaled $880.1 million in its fiscal first quarter, ended July 27, 2013, a decrease of 1.0 percent from $889.2 million in the year-earlier period. Net income was $45.9 million, or $0.45 per diluted share, compared to net income of $47.5 million, or $0.45 per diluted share, in the year-ago period. The company’s fiscal 2014 first quarter investment in information technology lowered diluted earnings per share by approximately $0.01.

Commenting on the company’s fiscal 2014 first quarter, Patterson Companies Chairman and Chief Executive Officer Scott P. Anderson said: “While we knew the first quarter would be challenging, results were in line with our expectations. We lapped exceptionally strong prior-year gains from a CEREC® trade-up program in our dental segment. We are encouraged by the increased consumable sales in the quarter in our dental and veterinary businesses, which typically signal strengthening underlying market conditions. This, along with the growth initiatives we have under way, gives us confidence in our full-year outlook.”

The company also announced that it plans to divest several non-core product lines in its medical segment. As a result, Patterson will incur a pre-tax restructuring charge in the range of $15-$17 million, or approximately $0.12 per diluted share, the majority of which will be taken in the fiscal 2014 second quarter. Divesting these product lines is estimated to generate operational savings of approximately $2 million, or $0.01 per diluted share, beginning in fiscal 2015.

Patterson Dental

Improved consumable sales in the fiscal 2014 first quarter were not enough to overcome the impact of a highly successful prior year CEREC trade-up program. As a result, sales for the Patterson Dental business decreased 2.3 percent from the year earlier period to $554.2 million. Patterson Dental comprised approximately two-thirds of total company sales. By category versus the year-ago quarter, sales of:
  • Consumable dental supplies rose 3.3 percent;
  • Dental equipment declined 11.7 percent; and
  • Other services and products, consisting primarily of technical service, parts and labor, software support services and artificial teeth, decreased 1.4 percent.

Anderson stated: “We are the proven leader in the dental equipment market, offering best-in-class technology and basic equipment that is wrapped with Patterson’s industry-leading after-sales support platform. Since the economic downturn, dentists have remained cautious about expanding and upgrading their basic practice infrastructure and we believe there is considerable pent-up demand for investments in their businesses. Additionally, sales of the new CEREC Omnicam®, which was introduced in fiscal 2013, are strong and meeting expectations. As a result, we are confident in the growth prospects for our dental equipment sales this fiscal year.”

1 of 5

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 16,472.37 +200.36 1.23%
S&P 500 1,951.36 +27.54 1.43%
NASDAQ 4,707.7750 +80.6910 1.74%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs